Skip to content

Prime E-CLASS XLPE Liner

by MicroPort Orthopedics Inc.

510(k) K181598

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK181598 Date14 Sep 2018ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LZO
FDA applicant
Microport Orthopedics, Inc.
Device Class
Class II
Regulation
21 CFR Part 888.3353
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Prime E-Class XLPE Liner is a hip joint prosthesis, semi-constrained, metal/ceramic/polymer, designed for cemented or non-porous uncemented fixation. It features a cross-linked polyethylene (XLPE) liner intended to articulate with a femoral component, providing stability and durability in total hip arthroplasty procedures. This device falls under the regulatory classification of 21 CFR 888.3353, ensuring compliance with orthopedic implant standards.

The Prime E-Class XLPE Liner is supplied sterile and intended for single-use in surgical settings. It is classified as Class II under FDA regulations and holds a 510(k) clearance (K181598) for substantial equivalence in orthopedic applications. Storage and handling must adhere to sterile medical device protocols, and its dimensions are standardized for compatibility with approved femoral components. No additional regulatory markings beyond the FDA clearance are specified.

Other devices from MicroPort Orthopedics Inc.

See all devices from MicroPort Orthopedics Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of hip procedures is the Prime E-Class XLPE Liner intended for, and how is it fixed in place?

    The Prime E-Class XLPE Liner is designed for total hip arthroplasty procedures, specifically to articulate with a femoral component. It is available in configurations for either cemented fixation or non-porous uncemented fixation, providing flexibility depending on the patient’s clinical needs and surgeon preference. The semi-constrained design enhances stability during articulation.

  • Is the Prime E-Class XLPE Liner reusable, or is it meant for single-use only?

    The Prime E-Class XLPE Liner is explicitly intended for single-use in surgical settings only. This aligns with standard sterile medical device protocols to ensure patient safety and prevent cross-contamination. Reuse is not recommended or supported by the manufacturer.

  • How should the Prime E-Class XLPE Liner be stored, and what sterility guarantees does it provide?

    The liner is supplied sterile and must be stored according to sterile medical device protocols to maintain its integrity. Since it is intended for single-use, it should be kept in its original packaging until immediately before use, following the manufacturer’s instructions to preserve sterility and prevent contamination.

  • What regulatory pathway was followed for FDA clearance of this device, and what does that mean for compatibility?

    The Prime E-Class XLPE Liner received FDA 510(k) clearance (K181598) under the traditional review pathway, with a decision of substantial equivalence (SESE) to a predicate device in orthopedic applications. This means it meets FDA standards for safety and effectiveness and is classified under 21 CFR 888.3353, ensuring compatibility with approved femoral components for total hip arthroplasty.